Stocks and Investing Stocks and Investing
Fri, April 26, 2019
Thu, April 25, 2019
Wed, April 24, 2019
Tue, April 23, 2019
Mon, April 22, 2019
Thu, April 18, 2019
Wed, April 17, 2019
Tue, April 16, 2019
Mon, April 15, 2019

Paul Matteis Maintained (ALNY) at Strong Buy with Increased Target to $116 on, Apr 15th, 2019


Published on 2024-10-26 13:05:40 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $110 to $116 on, Apr 15th, 2019.

Paul has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 2 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $70 on, Tuesday, April 9th, 2019
  • Esther Rajavelu of "UBS" Initiated at Hold on, Wednesday, January 23rd, 2019


This is the rating of the analyst that currently disagrees with Paul


  • David Lebovitz of "Morgan Stanley" Upgraded from Hold to Buy on, Tuesday, March 5th, 2019